Skip to main content
. 2019 May 7;120(12):1147–1152. doi: 10.1038/s41416-019-0470-1

Table 2.

Risk of gastric adenocarcinoma in participants exposed to prediabetes or diabetes compared with normoglycaemic participants, stratified by covariates, expressed as hazard ratio (HR) and 95% confidence interval (CI)

Stratified variable Gastric adenocarcinoma Crude modela Multivariable modelb
Number HR (95% CI) HR (95% CI)
Sex
 Male
  Normoglycemic 82 Reference Reference
  Prediabetes or diabetes 45 0.81 (0.56–1.17) 0.80 (0.55–1.16)
 Female
  Normoglycemic 50 Reference Reference
  Prediabetes or diabetes 42 1.24 (0.82–1.88) 1.20 (0.79–1.84)
Age at entry
 ≤49.5
  Normoglycemic 25 Reference Reference
  Prediabetes or diabetes 10 0.83 (0.39–1.77) 0.90 (0.42–1.93)
 >49.5
  Normoglycemic 107 Reference Reference
  Prediabetes or diabetes 77 1.00 (0.75–1.35) 0.98 (0.73–1.33)
Body mass index
 ≤25.4
  Normoglycemic 68 Reference Reference
  Prediabetes or diabetes 34 1.05 (0.70–1.60) 1.05 (0.69–1.59)
 >25.4
  Normoglycemic 64 Reference Reference
  Prediabetes or diabetes 53 0.90 (0.62–1.30) 0.90 (0.63–1.31)
Tobacco smoking status
 Current smoker
  Normoglycemic 39 Reference Reference
  Prediabetes or diabetes 33 1.22 (0.77–1.95) 1.21 (0.75–1.94)
 Ex-smoker
  Normoglycemic 41 Reference Reference
  Prediabetes or diabetes 24 0.89 (0.54–1.48) 0.81 (0.48–1.36)
 Non-smoker
  Normoglycemic 50 Reference Reference
  Prediabetes or diabetes 26 0.78 (0.48–1.26) 0.81 (0.50–1.32)

aAge was used as the time scale

bAdjusted for sex, calendar year, BMI, tobacco smoking status and education level at baseline; age was used as the time scale